Lilly, Insilico Ink Deal on AI Drugs Worth Up to $2.75 Billion - Bloomberg.com
Source:Bloomberg
Insilico Medicine Cayman TopCo’s shares jumped on Monday after it struck an artificial intelligence-driven drug development deal with Eli Lilly & Co. worth up to $2.75 billion.
Related Articles
Revolutionary Method Allows 3D Printing With Metal Harder Than Steel - SlashGear
While 3D printing has mostly involved plastic so far, future materials, including one harder than …
Bay Area canned food giant shuts down California plant, cutting 600 jobs - SFGATE
Del Monte Foods, the canned food giant based in Walnut Creek, is shutting down operations at its …
NAPA Owner Genuine Parts Plans to Split Into Two Companies - The Wall Street Journal
Company is preparing to separate its auto-parts and industrial-parts businesses
Experts Urge You to Put a Sticker on Your Credit Card—the Genius Security Hack Scammers Hate - Iowa Park Leader
None